Journals / Türk Biyokimya Dergisi / 2019 / Cilt: 44 - Sayı: 1

Alkaline phosphatase ınterference in an unconjugated estriol assay causing a false positive Down syndrome screening result

[Yanlış Pozitif Down Sendrom Tarama Sonucuna Sebep Olan Unkonjuge Estriol Testindeki Alkalen Fosfataz İnterferansı]

Pages
108–112
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Laboratories should be aware that falsely low uE3 results due to interference may be obtained.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Decreased unconjugated estriol (uE3) concentrations increase calculated risk of Down syndrome.
📊
Key Findings & Data:Therefore, falsely low uE3, due to assay interference, have the potential to cause false-positive screening results.
💡
Conclusion & Impact:Conclusion: Laboratories should be aware that falsely low uE3 results due to interference may be obtained.
🔬Design:Research Article
📍Scope:2000 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Decreased unconjugated estriol (uE3) concentrations increase calculated risk of Down syndrome. Therefore, falsely low uE3, due to assay interference, have the potential to cause false-positive screening results. Here we present a 35 years old woman with a pregnancy of 17 + 2 weeks. Materials and methods: Second-trimester screening test was performed on the UniCelDxI 800 (Beckman Coulter, Brea, CA, USA) analyzer and her uE3 level was 0.21 ng/mL (0.21 MoM). Risk calculated for DS was 1/8. Measurements were repeated on IMMULITE 2000 XPi (Siemens Healthcare Diagnostics Inc., USA). uE3 result was 0.614 ng/mL (0.97 MoM). The risk for DS was negative with this system. There was no sign of fetal anomaly on three-dimensional ultrasound examination and cell-free fetal DNA screening test. We suspected assay interference for uE3.Results: Serial dilutions of serum samples revealed nonlinearity. 36.3% increase was observed with heterophile antibody blocking tubes. The post-polyethylene glycol treatment resulted approximately the same uE3 levels as IMMULITE system. Addition of alkaline phosphatase Scavenger to serum increased the result by 90% showing that falsely low E3 result was due to an interferent reacting on assay medium. Conclusion: Laboratories should be aware that falsely low uE3 results due to interference may be obtained.

Özet

Amaç: Azalmış unkonjuge estriol (uE3) düzeyleri Down sendrom riskini arttırır. Bu yüzden, ölçüm interferansına bağlı yanlış düşük uE3 düzeyleri yanlış pozitif tarama sonuçlarının bulunmasına yol açar. Bu çalışmada 17 + 2 haftalık gebeliği olan 35 yaşındaki bir kadın olgu sunuldu. Gereç ve Yöntem: İkinci trimester tarama testi UniCelDxI 800 (Beckman Coulter, Brea, CA, USA) analizöründe ölçüldü ve uE3 düzeyi 0.21 ng/mL (0.21 MoM) bulundu. Down sendrom riski 1/8 olarak hesaplandı. Ölçümler IMMULITE 2000 XPi (Siemens Healthcare Diagnostics Inc., USA) analizöründe tekrarlandı. uE3 sonucu 0.614 ng/mL (0.97 MoM) bulundu. Down sendrom riski bu sistemde negatiftir. Üç boyutlu ultrason incelemesinde ve cell-free fetal DNA tarama testinde fetal anomali bulgusuna rastlanılmadı. Bulgular: Örneklerin seri dilusyonunda nonlinearite gözlendi. Heterofil antikor blokan tüpler ile %36.3 artış gözlendi. Polietilen glikol uygulama sonrası İmmulite sistemdeki sonuçlara benzer uE3 sonuçları saptandı. Seruma alkalen fosfataz scavenger eklenmesi sonrasında uE3 sonucunda %90 artış gözlendi. Yanlış düşük uE3 sonucunun reaksiyon ortamında bulunan interferana bağlı olduğu düşünüldü. Sonuç: Laboratuvar çalışanları ölçüm interferansına bağlı yanlış düşük uE3 düzeylerinin görülebileceğinin farkında olmalıdır.

🔖

Cite This Article

YILDIZ, Z., YÜCEL, N., ORÇUN, A., DAĞDELEN, L. K., MADENCİ, Ö. Ç., HÜRMEYDAN, Ö. (2022). Alkaline phosphatase ınterference in an unconjugated estriol assay causing a false positive Down syndrome screening result. Türk Biyokimya Dergisi, Cilt: 44 - Sayı: 1, 108–112. https://ajindex.com/articles/620877

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Dennis AW, Siu VM, Campagnolo C, Soldin SJ. Interference in an unconjugated estriol assay causing a false negative integrated prenatal screening report. Prenat Diagn 2010;30:165–7
  2. Tate J, Ward G. Interferences in immunoassay. Clin Biochem Rev 2004;25:105–20
  3. Mannings L, Trow S, Newman J, Nix B, Evans C. Interference in the autoDELFIA(R) hAFP immunoassay and effect on second-trimester Down’s syndrome screening. Ann Clin Biochem 2011;48:438–40
  4. Wald NJ. Guidance on terminology. J Med Screen 1994;1:76
  5. Fahie-Wilson MN, Smith TP. Determination of prolactin: the macroprolactin problem. Best Pract Res Clin Endocrinol Metab 2013;27:725–42
  6. Reinsberg J. Interferences with two-site immunoassays by human anti-mouse antibodies formed by patients treated with monoclonal antibodies: comparison of different blocking reagents. Clin Chem 1998;44:1742–4
  7. Butch AW, Goodnow TT, Brown WS, McClellan A, Kessler G, Scott MG. Stratus automated creatine kinase-MB assay evaluated: identification and elimination of falsely increased results associated with a high-molecular-mass form of alkaline phosphatase. Clin Chem 1989;35:2048–53
  8. Dasgupta A, Chow L, Wells A, Datta P. Effect of elevated concentration of alkaline phosphatase on cardiac troponin I assays. J Clin Lab Anal 2001;15:175–7
  9. Herman DS, Ranjitkar P, Yamaguchi D, Grenache DG, Greene DN. Endogenous alkaline phosphatase interference in cardiac troponin I and other sensitive chemiluminescence immunoassays that use alkaline phosphatase activity for signal amplification. Clin Biochem 2016;49:1118–21
  10. Ghali S, Lewis K, Kazan V, Altorok N, Taji J, Taleb M, et al. Fluctuation of spuriously elevated troponin I: a case report. Case Rep Crit Care 2012;2012:1–4.